Cizzle Bio Submits NIH Grant Proposal with Premier Research Institutions to Advance Biomarker Blood ...

SAN ANTONIO, July 8, 2025 /PRNewswire/ -- Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric cancers, has submitted a grant application to the National Institutes of Health (NIH), in partnership… ...[TheTopNews] Read More.